705256-69-5 Usage
Uses
Used in Medical Procedures:
3-(4-aminophenyl)-N-methylpropanamide (SALTDATA: FREE) is used as a local anesthetic for medical procedures such as dental work and minor surgeries. It is applied to numb specific areas of the body, allowing for pain-free treatment and interventions.
Used in Pain Management:
In the healthcare industry, 3-(4-aminophenyl)-N-methylpropanamide (SALTDATA: FREE) is utilized as an analgesic to alleviate acute and chronic pain. Its mechanism of action involves the inhibition of nerve impulse transmission, thus reducing the sensation of pain.
Used in Pharmaceutical Formulations:
3-(4-aminophenyl)-N-methylpropanamide (SALTDATA: FREE) is incorporated into various pharmaceutical formulations, such as creams, gels, and ointments, for topical application to treat localized pain and inflammation.
Used in Research and Development:
In the scientific community, 3-(4-aminophenyl)-N-methylpropanamide (SALTDATA: FREE) serves as a valuable compound for research purposes, particularly in the development of new anesthetics and analgesics, as well as in studies exploring the mechanisms of pain perception and nerve signal transmission.
Check Digit Verification of cas no
The CAS Registry Mumber 705256-69-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,5 and 6 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 705256-69:
(8*7)+(7*0)+(6*5)+(5*2)+(4*5)+(3*6)+(2*6)+(1*9)=155
155 % 10 = 5
So 705256-69-5 is a valid CAS Registry Number.
705256-69-5Relevant academic research and scientific papers
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents
Lu, Chenshu,Tang, Ke,Li, Yan,Li, Peng,Lin, Ziyun,Yin, Dali,Chen, Xiaoguang,Huang, Haihong
, p. 351 - 360 (2014/04/17)
A novel series of diaryl ureas containing different linker groups were designed and synthesized. Their in vitro antitumor activity against MX-1, A375, HepG2, Ketr3 and HT-29 was evaluated using the standard MTT assay. Compounds having a rigid linker group such as vinyl, ethynyl and phenyl showed significant inhibitory activity against a variety of cancer cell lines. Specifically, compound 23 with a phenyl linker group demonstrated broad-spectrum antitumor activity with IC50 values of 5.17-6.46 μM against five tested tumor cell lines. Compound 23 is more potent than reference drug sorafenib (8.27-15.2 μM), representing a promising lead for further optimization.
